Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins - Wikidata - awgldk - TriplyDB

Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins

Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins

http://www.wikidata.org/entity/Q34511878

about

Maillard reaction products and potatoes: have the benefits been clearly assessed?Vascular Effects of Dietary Advanced Glycation End Products Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms Phenolic acids inhibit the formation of advanced glycation end products in food simulation systems depending on their reducing powers and structures.

P2860

Q26752682-0EE60878-931C-4AD8-A472-C1233EED2F3F Q28081090-389557F1-2150-4CE4-839E-9E6BCA1D58EF Q33720039-9DBBF68A-E465-4168-8B98-10019E92BADE Q37636453-33996D74-E151-4D1E-B453-DF11B0E92D92 Q53616402-825FCDF4-914E-43AC-BF85-75F6DCC970BF

P2860

Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins

http://www.wikidata.org/entity/Q34511878

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@ast

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@en

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@nl

type

label

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@ast

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@en

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@nl

prefLabel

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@ast

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@en

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@nl

P1433

Q34511878-9ED8E408-19F4-4360-98B7-B4041B824822

P1476

Q34511878-56D2C99A-0375-4208-9692-765A7AF8E0FB

P2093

Q34511878-1F544A80-C4C0-45F5-9EC4-80C10A4F6B0B

Q34511878-6BB0339C-860D-429D-9730-DFA99C226C09

Q34511878-744FB6E6-0F7B-4EF6-8E89-8B116717E31A

Q34511878-97382AC4-6ADE-40D7-851E-C6E8656B95CA

Q34511878-9A78E671-CBA6-4AA4-9B98-D2A62A816163

Q34511878-B354D175-851D-4420-8C84-B99AA56F713C

Q34511878-F617ACA3-B9B5-48C5-B84A-AD9FC68F361A

P2860

Q34511878-134ADB26-DE96-41F6-B331-1138F81ED974

Q34511878-1CD8BDB3-7C97-4D9D-8C82-5A67EA8D02D2

Q34511878-1DA65E27-F486-4E1B-AEA7-B0CA03F0E2DA

Q34511878-1DEA0359-3457-4605-97DB-572734121F10

Q34511878-238E89C8-0904-493D-A94D-56482D36C9AE

Q34511878-62DF0A7E-DFD6-4FC6-8B38-B4F2CD48524E

Q34511878-639BB68A-A7DF-41C7-A5D0-6E0605F48F9D

Q34511878-6AF3790D-1890-4CC1-BA41-D54238079900

Q34511878-6DD2EF7E-CB80-4BE5-A29F-226968539DB7

Q34511878-7A050F01-7F71-46E3-92F8-5561B2EDDDB9

P304

Q34511878-4D82ACE0-884A-46F0-B77D-162C528D8A1A

P31

Q34511878-A696704C-8268-45FE-8BD5-D02F149F6176

P356

Q34511878-25659FC0-2708-4142-8886-D8F0B29F3987

P407

Q34511878-E9B023F6-3FD2-4019-95A0-2B21BDE96DEE

P433

Q34511878-C72AF8B9-66B6-459A-82DB-E647EB9AC584

P478

Q34511878-4D8590D0-8BCC-467B-AD7B-7C55281864D3

P577

Q34511878-320AD2FD-B1F9-4911-98D0-B4454B89E2DE

P5875

Q34511878-6BDF0AF4-9C85-4C47-B753-12236C4FFFC3

P698

Q34511878-BF903FAA-8934-4409-84E2-79345DB4ACED

P921

Q34511878-FB22FD16-2BB4-456F-A43B-13A2C511A56C

P932

Q34511878-66B0E1CB-B996-4E66-8E53-9A3F9276ADDA

P356

P1433

P1476

Acute macrovascular dysfunctio ...... nced glycated β-lactoglobulins

@en

P2093

Alin Stirban

http://www.w3.org/2001/XMLSchema#string

Christian Götting

http://www.w3.org/2001/XMLSchema#string

Diethelm Tschoepe

http://www.w3.org/2001/XMLSchema#string

Knut Franke

http://www.w3.org/2001/XMLSchema#string

Paraskevi Kotsi

http://www.w3.org/2001/XMLSchema#string

Ulf Strijowski

http://www.w3.org/2001/XMLSchema#string

Weijing Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation end products in foods and a practical guide to their reduction in the diet

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

Biochemistry and molecular cell biology of diabetic complications

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

Primary endothelial dysfunction: atherosclerosis.

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.

Glycoxidation: the menace of diabetes and aging.

Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline.

P304

1278-1282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-1489

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233914300

http://www.w3.org/2001/XMLSchema#string

P698

23238657

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3631855

http://www.w3.org/2001/XMLSchema#string